Comparing the current results to its competitors, Irhythm Holdings Inc reported Revenue increase in the 1 quarter 2026 by 26 % year on year. The sales growth was above Irhythm Holdings Inc 's competitors' average revenue growth of 15.25 %, achieved in the same quarter.
Irhythm Holdings Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 20.28 %
Irhythm Holdings Inc 's Comment on Competition and Industry Peers
The company operates in the remote cardiac monitoring market, which is characterized by significant competition and ongoing technological advancements. Its competitors include BioTelemetry, Inc. (acquired by Royal Philips), Preventice Solutions, Inc. (acquired by Boston Scientific, Inc.), and Bardy Diagnostics, Inc. (acquired by Hill-Rom Holdings, Inc., now part of Baxter International, Inc.), all of which provide remote cardiac monitoring technology and diagnostic services. The company also competes with providers of traditional 24-to-48-hour Holter monitors, such as GE Healthcare, Philips Healthcare, Spacelabs Healthcare Inc., Welch Allyn Holdings, Inc. (acquired by Hill-Rom Holdings, Inc., now part of Baxter International, Inc.), and Mortara Instrument, Inc. (also acquired by Hill-Rom Holdings, Inc., now part of Baxter International, Inc.). Many competitors possess greater financial, manufacturing, marketing, and technical resources, as well as established brands and distribution networks.
March 27, 2024
The Gross Law Firm recently issued a notice to shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), urging them to get in touch before April 8, 2024, to discuss their rights. This announcement has caught the attention of investors and is bound to shape the future course of action for the company and its stakeholders.Factual Outline:iRhythm Technologies, Inc., a prominent medical technology company listed on NASDAQ under the symbol IRTC, is currently facing a situation that necessitates shareholders attention. The Gross Law Firm, a renowned securities litigation firm, released the notice on March 27, 2024, alerting shareholders about the importance of discussing their rights before the impending date o...
February 26, 2024
In recent years, technological advancements have revolutionized the healthcare industry, bringing about innovative solutions for patient care and disease management. iRhythm Technologies, Inc., a prominent player in the field, has gained significant attention for its expertise in wearable digital healthcare solutions. However, the company recently found itself embroiled in a securities fraud class action lawsuit that has sent shockwaves through the investor community. In this article, we will delve into the case surrounding iRhythm Technologies, evaluating its potential impact on investors and the broader healthcare technology sector.The Allegations:On February 26, 2024, Levi and Korsinsky, LLP, a renowned s...
January 4, 2024
In a landmark collaboration aimed at empowering girls and women s golf, the ANNIKA Foundation has joined forces with Babygrande Golf to enhance content production and marketing capabilities. This strategic partnership promises to delve deeper into the unique stories of top junior girls and amateur women participating in the Foundation s renowned annual U.S. tournaments, amplifying their exposure and inspiring the next generation of female golfers.Renowned golfer Annika Sorenstam s ANNIKA Foundation recently announced an exciting partnership with Babygrande Golf, a forward-thinking content production and marketing company. This collaboration aims to leverage digital platforms and creative narratives to bring...
Integra Lifesciences Holdings Corp's business model revolves around developing, manufacturing, and selling medical devices and instruments to healthcare providers.
Ir med Inc's business model involves providing innovative medical technologies and solutions to the healthcare industry. The company focuses on developing and commercializing advanced medical devices that aim to improve patient outcomes and enhance overall healthcare management.
Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.
Microbot Medical Inc is a medical device company that focuses on the research, development, and commercialization of surgical solutions. Their business model revolves around creating innovative robotic technologies and tools for minimally invasive surgeries, catering to various medical specialties.
Sources:
Irhythm Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Irhythm Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
